Star Therapeutics’ $90 Million Series C Financing Round

Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Star Therapeutics in the transaction.Star Therapeutics announced its oversubscribed $90 million Series C financing to continue growth of its first-in-class…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here